Search Results - "Tan, Darrell HS"

Refine Results
  1. 1
  2. 2
  3. 3

    Sexual health promotion for sexual and gender minorities in primary care: a scoping review protocol by Homme, Paige, Truong, Robinson, Gong, Jenny, Ziegler, Carolyn, Freitas, Cassandra, Yeung, Anna, Tan, Darrell HS, Burchell, Ann N

    Published in BMJ open (03-03-2023)
    “…IntroductionSexual and gender minorities (SGMs) face health disparities related to systemic discrimination and barriers to sexual health. Sexual health…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009 by Burchell, Ann N, Allen, Vanessa G, Moravan, Veronika, Gardner, Sandra, Raboud, Janet, Tan, Darrell H S, Bayoumi, Ahmed M, Kaul, Rupert, Mazzulli, Tony, McGee, Frank, Millson, Peggy, Remis, Robert S, Rourke, Sean B

    Published in BMC infectious diseases (28-05-2013)
    “…Since 2000, reported syphilis cases increased ten-fold in Canada, particularly among men who have sex with men (MSM) co-infected with HIV. We characterized…”
    Get full text
    Journal Article
  6. 6

    Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial by Tan, Darrell H S, Raboud, Janet M, Kaul, Rupert, Grinsztejn, Beatriz, Cahn, Pedro, Walmsley, Sharon L

    “…Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-related morbidity and mortality, the associated costs, toxicities, and…”
    Get full text
    Journal Article
  7. 7

    An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV by Christensen, Brandon L, Tan, Darrell Hs

    Published in Expert opinion on pharmacotherapy (04-03-2022)
    “…There are more than 30 agents available for the treatment of HIV with guidelines shifting toward integrase strand transfer inhibitors (INSTIs) as part of first…”
    Get more information
    Journal Article
  8. 8

    HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV by McClymont, Elisabeth, Tan, Darrell Hs, Bondy, Suraya, Albert, Arianne, Coutlée, François, Lee, Marette, Walmsley, Sharon, Ogilvie, Gina, Money, Deborah

    Published in International journal of STD & AIDS (01-05-2023)
    “…Several co-factors for HPV oncogenesis have been proposed, including co-infection with HSV-2. We assessed the relationship between HSV-2 infection and…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures by Clifford Rashotte, Matthew, Yoong, Deborah, Naccarato, Mark, Pico Espinosa, Oscar J, Fisher, Karla, Bogoch, Isaac I, Tan, Darrell Hs

    Published in International journal of STD & AIDS (01-05-2024)
    “…PEP-In-Pocket (Post-Exposure Prophylaxis-In-Pocket, or "PIP") is a biobehavioural HIV prevention strategy wherein patients are proactively identified and given…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis by Knox, David C, Anderson, Peter L, Harrigan, P. Richard, Tan, Darrell H.S

    Published in The New England journal of medicine (02-02-2017)
    “…This letter indicates that infection with HIV type 1 can occur despite preexposure prophylaxis with combination antiretroviral therapy. To the Editor:…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis by Yoong, Deborah, Naccarato, Mark, Sharma, Malika, Wilton, James, Senn, Heather, Tan, Darrell Hs

    Published in International journal of STD & AIDS (01-07-2016)
    “…Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but has the potential to cause harm if not used properly. Pharmacists are…”
    Get more information
    Journal Article
  16. 16

    Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review by Sivarajah, Vishalini, Venus, Kevin, Yudin, Mark H, Murphy, Kellie E, Morrison, Steven A, Tan, Darrell Hs

    Published in Sexually transmitted infections (01-12-2017)
    “…Reducing HIV mother-to-child transmission (MTCT) is critical to ending the HIV pandemic. Reports suggest that herpes simplex virus-2 (HSV-2), a common…”
    Get more information
    Journal Article
  17. 17

    Global plagues and the Global Fund: Challenges in the fight against HIV, TB and malaria by Tan, Darrell HS, Upshur, Ross EG, Ford, Nathan

    Published in BMC international health and human rights (01-04-2003)
    “…BACKGROUND: Although a grossly disproportionate burden of disease from HIV/AIDS, TB and malaria remains in the Global South, these infectious diseases have…”
    Get full text
    Journal Article
  18. 18

    Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act by Burgoyne, Robert W., Tan, Darrell H. S.

    Published in Journal of antimicrobial chemotherapy (01-03-2008)
    “…Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some…”
    Get full text
    Journal Article
  19. 19

    Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations by Senn, Heather, Wilton, James, Sharma, Malika, Fowler, Shawn, Tan, Darrell H S

    Published in AIDS research and human retroviruses (01-09-2013)
    “…Oral daily tenofovir/emtricitabine (Truvada) is approved in the United States for HIV preexposure prophylaxis (PrEP) but has generated controversy in the media…”
    Get more information
    Journal Article
  20. 20